Enteral insufficiency syndrome: current provisions about the terminology, pathogenesis and treatment (review of literature)
https://doi.org/10.24884/0042-4625-2020-179-6-101-106
Abstract
An analytical review of the literature on the pathogenesis of disorders of the motor-evacuation function of the intestine, which underlies the enteral insufficiency syndrome (EIS), which develops in various acute intra-abdominal surgical diseases, is presented. On the basis of a multivariate analysis of literature data, various pathogenetic mechanisms of enteric dysfunctions caused by morphological and structural changes in the wall of the small intestine, violations of its local defense mechanisms are described. The essence of the modern concept of the pathogenesis of enteral insufficiency – enteral distress syndrome (EDS) according to the literature is presented. According to new views, EDS is a combination of various pathogenetic mechanisms that are formed as a result of dysregulation and destabilization of biological membranes of tissue structures of the intestinal wall (especially its mucous membrane) and a violation of the functional and metabolic status of the intestine, developing in acute surgical diseases of the abdominal organs. Recognition of the validity of the concept will allow unifying the terminology and creating more evidence-based and generally accepted teaching about the nature of EIS.
About the Authors
S. A. AlievAzerbaijan
Aliev Saday A., Dr. of Sci. (Med), Professor of the Department of Surgical Diseases № 1
100, Bratev Mardanovykh str., Baku
E. S. Aliev
Azerbaijan
Aliev Emil S., Cand. of Sci. (Med), Assistant of the Department of Surgical Diseases № 1
Baku
References
1. Gain Yu. M., Leonovich S. I., Alekseev S. A. Enteral’naya nedostatochnost’ pri peritonite: teoreticheskie i prakticheskie aspekty, diagnostika i lechenie. Molodechno, 2001:265. (In Russ.).
2. Blaser A. R., Ploegmakers I., Benoit M. Acute intestinal failure: International multicenter pointofprevalence study // Clin. Nutr. 2020;39(1):151–158. Doi: 10.1016/j.clnu.2019.01.005.18.
3. Dibirov M. D., Aliev A.M., Talkhanov V. M. Sindrom kishechnoj nedostatochnosti i ego korreksija pri pankreatogennom endotoksikoze. Vrach skoroj pomoshi. 2014;(1):58–64. (In Russ.).
4. Ermolov A. S., Popova T. S., Pahomova G. E., Uteshev N. S. Sindrom kishechnoj nedostatochnosti v neotlozhnoj abdominal’noj khirurgii. Moscow, Medekspert, 2005:460. (In Russ.).
5. Makedonskaja T. P., Pahomova G. V., Popova T. S., Selina I. E., Skvorsova A. V. Lechenije sindroma kishechnoj nedostatochnosti u bol’nyh s peritonitom. Khirurgija. 2004;(10):31–33. (In Russ.).
6. Savel’jev V. S., Lubjanskij V. Q., Petuhov V. A., Son D. A., Romanenko K. V., Mironov A. V. Dismetabolicheskie posledstvija sindroma kishechnoj nedostatochnosti v abdominalnoj khirurgii. Annaly khirurgii. 2005;(6):46–54. (In Russ.).
7. Hrupkin V. I., Alekseev S. A. Sindrom enteral’noj nedostaochnosti u bol’nyh s rasprostranennym peritonitom: ocsenka stepeni tyazhesti i ishoda processa. Vestnik khirurgii im. I. I. Grekova. 2004;(2):46–49. (In Russ.).
8. Huang J. C., Yeh C. C., Hsich C. H. Laproscopic management for Seprafilminduced sterile peritonitis with paralytic ileus of 2 cases. J. Minim. Invasive Gynecol. 2012;19(5):663–666.
9. Petuhov V. A. Lipidnyj distresssindrom. Diagnostika i printsipy lechenija. Posobie dlja vrachej. Ed. by V. S. Savel’ev. Moscow, VEDI, 2003:88. (In Russ.).
10. Mapesa J. O., Maxwell A. L., Ryan E. P. An exposome perspective on environmental enteric dysfunction // Environ. Health Perspect. 2016; 124(8): 1121–1126. Doi: 10.1289/ehp.1510459.
11. Kosinеtc V. А. Sindrom entеrаl’noy nеdostаtochnosti: pаtogеnеz, sovrеmеnnyе printcipy diаgnostiki i lеchеniya. Novosti khirurgii. 2008; 16(2):130–138. (In Russ.).
12. Uzankichyan A. A., Asatryan A. R., Zakaryan A. E., Mhitaryan A. G., Akopyan G. R., Pogosyan G. A., Zakaryan Z. A., Minasyan A. A. K voprosu izuchenija patogeneza enteral’noj nedostatochnosti u bol’nyh s rasprostranennym posleoperacionnym peritonitom. Khirurgija. 2010;(11):42–47. (In Russ.).
13. Denno D. M., Tarr P. I., Nataro J. P. Environmental enteric dysfunction: a case definition for intervention trials // Am. J. Trop. Med. Hyg. 2017; 97(6):1643–1646. Doi: 10.4269/ajtmh170183.
14. Beyer K., Menges P., Kessler W., Heidecke C.D. Pathophysiologie der Peritonitis. Der Chirurg. 2016;87(1):5–12.
15. Xu D. Z., Lu Q., Kibicka R., Deitch E. A. The effect of hypoxia/reoxygenation on the cellular function of intestinal epithelial cells. J. Trauma. 1999;(46):280–285.
16. Alekseev S. A. Abdominal’nyj khirurgicheskij sepsis. Minsk, Yunipak, 2005:256. (In Russ.).
17. Vlasov A. P., Salahov E. K., Shibitov V. A., Vlasov P. A., Bolotskih V. A. Kompleksnyj podhod k korrekcii enteral’noj nedostatochnosti v rannem posleoperacionnom periode. Khirurgija. 2016;(5):52–58. (In Russ.). Doi: 10.17116/hirurgia 2016 5 5258.
18. Takha Kh. D.,Allniazi A. E., Amakhanov A. K., Inyutin A. S. Features of enteric insufficiency syndrome in patients with widespread peritonitis // Kazan Medical Journal. 2015;96(4):489–492. (In Russ). Doi: 10.177550/KMJ 2015489.
19. Milyukov V. E., Sharifova Kh. M. Multiple organ manifestations of liver failure in acute small bowel obstruction // Pirogov Journal of Surgery. 2019;(9):73–79. (In Russ). Doi: 10.17116/hirurgia 201909173.
20. Zhang F., Tong L., Qiao H., Dong X., Qiao G., Jiang H., Sun X. Taurine attenuates multiple organ injury induced by intestinal ishemiareperfusion in rats // Surg. Res. 2008;149(1):101–109. Doi: 10.1016/j.jss. 2007.12.781.
21. Breаley D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N. A., Cooper C. E., Singer M. Association between mitochondrial disfunction and severity and outcome of septic shock. Lancet. 2002; 360(9328):219–223.
22. Overhaus M., Togel S., Perrone M. A., Baner A. J. Mechanisms ofpolymicrobial sepsisinduced ileus. Am. J. Physiol. Gastrointestin. Liver Physiol. 2004;287(3):685–694.
23. Sun X., Shao Y., Jin Y., Huai J., Zhou Q., Huang Z., Wu J. Melatonin reduces bacterial translocation by preventing damage to the intestinal mucosa in an experimental severe acute pancreatitis rat model. Exp. Ther. Med. 2013;6(6):1343–1349.
24. Xu D. Z., Lu Q., Quillery D., Cruz N., Berg R. D., Deitch E. A. Mechanizmz of endotoxin – induced intestinal injury in a hyperdynamic model of sepsis. J. Trauma. 1993;34:676–683.
25. Rummo O. O. Intrаintеstinаl’nаya tеrаpiya sindromа entеrаl’noy nеdostаtochnosti pri pеritonitе, kishеchnoy nеprokhodimosti i dеstruktivnom pаnkrеаtitе. Mеditcinskiy zhurnаl. 2000;2(28):15–19. (In Russ.).
26. Yoseph B. P., Klingensmith N. J., Liang Z., Breed E. R., Burd E. M., Mittal R., Dominguez J. A., Petrie B., Ford M. L., Coopersmith C. M. Mechanisms of intestinal barrier dysfunction in sepsis // Shock. 2016; 46(1):52–59. Doi: 10.1097/SHK0000000000000565.
27. Kirkovskiy V. V., Tret’yak S. I., Merzlyakov A. E., Rummov O. O. Korrekciya intestnal’noqo statusa u bol’nyh s rasprostranennym peritonitom. Khirurgiya. 2000;(9):11–15. (In Russ.).
28. Hrupkin V. I., Hanevich M. D., Shestopalov A. E., Shpak E. G., Starokon’ P. M. Enteral’naja terapija sindroma kishechnoj nedostatochnostiu bol’nyh peritonitom. Vestnik khirurgii im. I. I. Grekova. 2003;162(6):16–19. (In Russ.).
29. Carlson G. L. Surgical management of intestinal failure. Proceeding of the nutrition Society. 2003;(62):711–718.
30. Deshpande A., Pasupuleti V., Thota P., Pant C., Mapara S., Hassan S., Rolston D. D., Sferra P. J., Hernandez A. V. Acidsupressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a metaanalysis. J. Gastroenterol Hepatol. 2013;(28):235–242.
31. Vlasov A. P., Trofimov V. A., Grigor’eva T. I., Shibitov V. A., Vlasov P. A. Enteral’nyj distresssindrom v khirurgii: ponyatie, patogenez, diagnostika. Khirurgija. 2016;(11):48–53. (In Russ.). Doi: 10.17116/hirurgia2016114853.
32. Klek S., Forbes A., Gabe S., Holst M., Wanten G., Irtum O., Damink S. O., PanisicSekeljic M., Pelaez R. B., Pironi L., Blaser A. R. et al. Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN). Special Interest Group // Clinical Nutrition. 2016;(35):1209–1218. Doi: 10.1016/j.clnu2016.04.009.
33. Grainger J. T. Maeda Y., Donnelly S. C., Vaizey C. J. Assessment and management of patients with intestinal failure: a multidisciplinary approach // Clin Exp Gastroenterol. 2018;(11):233–241. Doi: 10.2147/CEG.S 122868.
34. Voronkov D. E., Kostyrnoj A. V., Barannikov K. V. Korrekcija narushenij mikrosirkuljacii i obmennyh processov, profilaktika sindroma enteral’noj nedostatochnosti pri peritonite. Tavricheskij medikobiologicheskij vestnik. 2013;16(64):34–38. (In Russ.).
35. Shibitov V. A., Vlasova T. I., Polozova P. A., Vlasov P. A., Anaskin S. G., Matveeva M. V. Pathogenetic aspects of enteric insufficiency // Fundamental Research. 2012;4(part 1):152–156. (In Russ.). Available at: http://www.fundamentalresearch.ru/ru/article/view?id=29734 (accessed: 01.03.2012).
36. Schultz K., Sommer O., Jargon D., Utzolino S., Clement H.W., Strate T., Dobschuets E. Cytokine and radical inhibition in septic intestinal barrier failure. Journal of Surgical Research. 2015;193(2):831–840.
37. Sun Z., Wang X., Deng X., Börjesson A., Wallen R., Hallberg E., Andersson R. Phagocytic and intestinal endothelial and epithelial barrier function during the early stage of small intestinal ischemia and perfusion injur. Shok. 2000;(3):209–216.
38. Guo Z. Z., Wange P., Yi Z. H. The crosstalk between gut inflammation and gastrointestinal disorders during pancreatitis. Curr. Pharm. Des. 2014;20(7):1051–1062.
39. Kalff J. C. Surgical manipulation of the gut elicits and intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann. Surg. 2007;(1):228–232.
40. Pastores S. M., Katz D. P., Kvetan V. Splanchnic ischemia and gut mucosal injury sepsis and the multiple organ dysfunction syndrome. Amer. J. Gastroenterol. 1996;91(9):1697–1710.
41. Marshall J. C., Christon N. V., Meakins J. L. The gastrointestinal tract. The “undreined abscess” of multiple organ failure. Ann. Surg. 1993; 218(2):111–119.
42. Drewe J., Berlinger C., Fricker G. Effect of ischemia on intestinal permeability. Eur. J. Clin. Invest. 2000;31(2):138–144.
43. Grotz M. R., Deitch E. A., Ding J., Xu D., Huang Q., Regel G. Intestinal cytokine response after gut ishemia. role of gut barrier failure. Ann. Surg. 1999;229(4):478–486.
44. Belik B. M. Ocenka klinicheskoj effektivnosti preparata serotoninaadipinata v lechenii i profilaktiki sindroma enteral’noj nedostatochnosti pri rasprostranennom peritonite. Khirurgija. 2016;(9):76–82. (In Russ.). Doi: 10.17116/hirurgia2016 97682.
45. Simonenko A. P., Fedorov V. D. Profilaktika i lechenije serotoninovoj nedostatochnosti u khirurgicheskih bol’nyh. Khirurgija. 2003;(3):76–80. (In Russ.).
46. Akiho H., Ihara E., Motomura Y., Nakamura K. Cytokineinduced alterations of gastrointestinal motility in gastrointestinal discords. World. J. Gastrointest. Pathophysol. 2011;2(5):72–81.
47. Hendriks T., Bleichordt J. M., Lomme R. M., De Man B. M., van Goor H., Buyne O. R. Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat. J. Am. Coll. Surg. 2010;211(2): 263–270.
48. Christopher T. Capaldo, Asma Nusrat. Cytokine regulation of tight junctions // Biochemica et Biophysica Acta (BBA) Biomembranes. 2009; 1788(4):864–871. Doi: https://doi.org/10.1016/j.bbamem.2008.08.027.
49. Schwart N. T., Engel B., Eskandari M. K., Kalff J. C., Grandis J. R., Bauer A. J. Lypopolysaccharide preconditioning and crosstolerance: the induction of protective mechanisms for rat intestinal ileus. Gastroenterology. 2002;123(2):586–598.
50. Kosinec V. A. Vlijanie preparata jantarnoj kisloty «Reamberina» na funkcional’nuju aktivnost’ mitohondrij myshechnogo sloja tonkoj kishki pri rasprostranennom gnojnom peritonite. Novosti khirurgii. 2007;15(4): 8–15. (In Russ.).
Review
For citations:
Aliev S.A., Aliev E.S. Enteral insufficiency syndrome: current provisions about the terminology, pathogenesis and treatment (review of literature). Grekov's Bulletin of Surgery. 2020;179(6):101-106. (In Russ.) https://doi.org/10.24884/0042-4625-2020-179-6-101-106